Plasma Fractionation Market to Reach $23.00 Bn, Globally, by 2027 at 6.2% CAGR: Allied Market Research

PORTLAND, Ore., Sept. 16, 2020 /PRNewswire/ --  Allied Market Research published a report, titled, "Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Coagulation Factor VIII and Coagulation Factor IX), Sector (Public Sector and Private Sector): Global Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the global plasma fractionation industry was estimated at $18.22 billion in 2019, and is expected to hit $23.00 billion by 2027, registering a CAGR of 6.2% from 2020 to 2027.

Request for Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/943?reqfor=covid 

Drivers, restraints, and opportunities-

Rise in geriatric population across the world, increase in the prevalence of rare diseases, surge in use of immunoglobulins in medicine, and emergence of plasma collection centers in different countries fuel the growth of the global plasma fractionation market. At the same time, high cost of plasma derived products impedes the growth to some extent. Nevertheless, high growth potential in emerging economies is expected to create lucrative opportunities in the industry.

Covid-19 scenario-

• The outbreak of the pandemic has led to postponements of planned surgeries across the world. Cases of hospital admission have also been declined to a great extent. Accordingly, the global plasma fractionation market has been impacted negatively.
• However, the situation is ameliorating gradually and the market is expected to get back to its stance soon.

The immunoglobulin segment to dominate by 2027-

Based on product, the immunoglobulin segment contributed to more than two-thirds of the global plasma fractionation market share in 2019 and is expected to retain its dominance during the study period, owing to the diversified use of immunoglobulin in various disorders such as primary and secondary immune deficiencies, autoimmune diseases, and inflammatory diseases. The albumin segment, on the other hand, would register the fastest CAGR of 6.7% till 2027, due to surge in the number of surgical procedures which demand the use of albumin.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/943

The private sector segment to lead the trail-

Based on sector, the private sector accounted for more than three-fifths of the global plasma fractionation market revenue in 2019 and is projected to rule the roost throughout the forecast period. The same sector would also grow at the fastest CAGR of 6.3% by the end of 2027. This is attributed to the fact that there is a huge presence of private players operating in the plasma fractionation industry that collect and fractionate larger amount of plasma as compared to public sector.

Canada had the major share in 2019-

Based on geography, Canada held the largest share, garnering 0.03% of the global plasma fractionation market. At the same time, Taiwan would portray the fastest CAGR of 9.0% by 2027. This is due to the factors such as surge in adoption of plasma fractionation derivatives, and rise in healthcare expenditure.

Frontrunners in the industry-

• Baxter International Inc
• Takeda Pharmaceuticals
• CSL LTD.
• Grifols SA
• Bio Product Laboratory
• Sanquin
• LaboratoireFranais Du FractionnementEt DesBiotechnologies
• Octapharma AG
• Kedrion
• Biotest

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Similar Reports:

Fluid Management Devices Market Global Opportunity Analysis and Industry Forecast, 2020–2027

Gastric Band Devices Market Global Opportunity Analysis and Industry Forecast, 2019-2026

Orthopedic Surgical Power Tools Market Global Opportunity Analysis and Industry Forecast, 2019-2026

Airway Management Products (AMD) Market Global Opportunity Analysis and Industry Forecast, 2019–2026

Macular Edema Market Global Opportunity Analysis and Industry Forecast, 2019–2026

Medical Incubator Market Global Opportunity Analysis and Industry Forecast, 2019–2026

Medical Vacuum Systems Market Global Opportunity Analysis and Industry Forecast, 2019–2026

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research 

SOURCE Allied Market Research